Odyssey Gold Limited (ASX:ODY) Commences Technical Study for Tuckanarra Project
Odyssey Gold Limited (ASX:ODY) has launched a Technical Study to evaluate mining and processing options for its Tuckanarra Gold Project.
Tag: Corporate Strategy & Guidance
Immutep Limited (ASX:IMM) Reports Q3 FY25 Milestones and Financial Position
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.
BrainChip Holdings Ltd (ASX:BRN) Releases Q1 2025 Activities Report
BrainChip Holdings Ltd (ASX:BRN) releases Q1 2025 report, highlighting key partnerships and a solid financial position.
G8 Education Limited (ASX:GEM) Announces 2025 AGM Highlights
G8 Education Limited (ASX:GEM) reports a 14.8% EBIT increase and highlights strategic initiatives during its 2025 AGM.
Radiopharm Theranostics (ASX:RAD) Begins Phase 2b U.S. Trial for 18F-RAD101
Radiopharm Theranostics (ASX:RAD) initiates Phase 2b U.S. trial of 18F-RAD101, advancing diagnostic capabilities for brain metastasis.
Unibail-Rodamco-Westfield (ASX:URW) Announces Q1 2025 Trading Update
Unibail-Rodamco-Westfield (ASX:URW) reports strong Q1 2025 performance, confirms earnings guidance, and completes significant asset disposals.
NOVONIX (ASX:NVX) Appoints Michael O’Kronley as CEO
NOVONIX (ASX:NVX) appoints Michael O’Kronley as CEO, marking a significant leadership change within the company.
Orthocell Limited (ASX:OCC) Gains Thai FDA Approval for Remplir™
Orthocell (ASX:OCC) receives Thai FDA approval to launch Remplir™, expanding into the US$84 million nerve repair market.
Lynas Rare Earths Ltd (ASX:LYC) Announces Q3 FY25 Quarterly Report
Lynas Rare Earths Ltd (ASX:LYC) reports Q1 FY25 sales revenue of A$123m and initiates production of Dysprosium, reinforcing its strategic position in the rare earths market.
Eagle Mountain Mining (ASX:EM2) Completes Rights Issue
Eagle Mountain Mining (ASX:EM2) completes rights issue, raising A$5.9 million and advancing key projects.